Veracyte, Inc.
VCYT
$26.76
-$1.17-4.19%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 7.05M | 5.11M | 15.16M | 5.73M | -1.86M |
| Total Depreciation and Amortization | 5.36M | 6.25M | 5.88M | 5.74M | 5.59M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.34M | 17.36M | 9.02M | 12.30M | 10.14M |
| Change in Net Operating Assets | -15.39M | -4.20M | -91.00K | 5.80M | -22.83M |
| Cash from Operations | 5.36M | 24.52M | 29.96M | 29.58M | -8.97M |
| Capital Expenditure | -1.82M | -4.14M | -2.24M | -2.77M | -2.13M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 0.00 | 0.00 | 0.00 | 5.01M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -50.00M | -50.00M | -- | -- | -- |
| Cash from Investing | -51.82M | -54.14M | -2.24M | -2.77M | 2.88M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.97M | 3.26M | 12.47M | 1.29M | 2.97M |
| Repurchase of Common Stock | -9.45M | -3.27M | -2.18M | -1.30M | -3.83M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -4.50M | -- | -- | -- |
| Cash from Financing | -6.48M | -4.51M | 10.29M | -11.00K | -864.00K |
| Foreign Exchange rate Adjustments | 74.00K | -401.00K | 146.00K | -61.00K | -108.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -52.87M | -34.53M | 38.16M | 26.73M | -7.06M |